期刊文献+

人源化抗Aβ抗体治疗APP/PS1转基因鼠的实验研究 被引量:1

Experiment research of APP /PS1 transgenic mice's treatment with humanization anti-amyloid-β antibodies
下载PDF
导出
摘要 目的初步探讨人源化抗Aβ抗体对APP/PS1转基因鼠被动免疫治疗效果。方法选取36只APP/PS1转基因鼠,随机分为3组,每组各12只,分别予腹腔注射人源化抗Aβ抗体、鼠源性单克隆抗体、磷酸盐缓冲液(PBS),观察3组小鼠脑内淀粉样斑块积聚情况,测试其学习记忆能力,同时检测血清及脑内TNF-α含量。结果人源化抗Aβ抗体组、鼠源性单克隆抗体组小鼠空间辨别学习记忆能力均优于PBS对照组(P<0.05),人源化抗Aβ抗体组与鼠源性单克隆抗体组间比较差异无统计学意义(P>0.05);治疗后人源化抗Aβ抗体组与鼠源性单克隆抗体组小鼠大脑皮质、海马区棕色斑块沉积明显形态变小、数量变少、范围分散。人源化抗Aβ抗体组与鼠源性单克隆抗体组脑内TNF-α含量均较PBS对照组明显减少(P<0.05)。结论人源化抗Aβ抗体治疗转基因小鼠后明显改善其学习记忆能力,同时使其脑内TNF-α含量减少。 Objective To preliminarily explore the effect of passive immunity treatment for APP/PS1 transgenic mice with humanization anti-amyloid-βantibodies.Method Thirty-six APP/PS1 transgenic mice were selected and randomly divided into 3 groups.Experimental group(n=1 2)was intraperitoneal injected with humanization anti-amyloid-βantibodies,positive control group was intraperitoneal injected with monoclonal an-tibody,negative control group was intraperitoneal injected with PBS.The accumulation of the amyloid plaques in the brain and the ability of learning and memory were observed.The levels of TNF-αin serum and brain were detected.Result The mice’s ability of learning and memory in space identification of experimental group and positive control group,were statistically better than that of negative control group (P〈0.05).However, there is no statistically difference between experimental group and positive control group (P〉0.05).With the treatment of humanization anti-amyloid-βantibodies and monoclonal antibody ,the brown plaque deposition in mice’s brain cortex and hippocampus were obviously smaller,with less number and dispersive range.The levels of TNF-αin brain in experimental group and positive control group decreased significantly when compared with negative control group (P〈0.05).Conclusion For transgenic mice,humanization anti-amyloid-βantibod-ies could obviously improve their learning and memory ability,and increase the level of TNF-αin brain.
出处 《新医学》 2014年第2期95-98,共4页 Journal of New Medicine
关键词 阿尔茨海默病 β-淀粉样蛋白 老年斑 MORRIS 水迷宫行为学测试 肿瘤坏死因子-α TNF-α Alzheimer’s Disease β-amyloid protein Senile plaque Morris water maze behavior test
  • 相关文献

参考文献6

  • 1马芹颖,王彦永,马晓伟,王铭维.快速老化小鼠SAMP8的增龄性老化特征研究[J].新医学,2013,44(6):415-419. 被引量:9
  • 2Wirths 0, Breyhan H, Marcello A, et al. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1 KI mouse model of Alzheimer's disease. Neurobiol Aging, 2010, 31: 747-757.
  • 3Sohn JH, So JO, Hong HJ, et al. Identification of autoantibody against beta-amyloid peptide in the serum of elderly. Front Biosci (Landmark Ed), 2009, 14: 3879-3883.
  • 4Kellner A, Matschke J, Bemreuther C, et al. Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Ann Neurol , 2009, 65: 24-31.
  • 5Relkin NR, Szabo P, Adamiak B, et al. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease. Neurobiol Aging, 2009, 30: 1728- 1736.
  • 6Fillit H, Hess G, Hill J, et al. IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders. Neurology, 2009, 73: 180-185.

二级参考文献9

  • 1Takeda T, Hosokawa M, Takeshita S, et al. A new mu- rine model of accelerated senescence. Mech Ageing Dev, 1981, 17: 183-194.
  • 2Kawamata T, Akiguchi I, Yagi H, et al. Neuropathologi-cal studies on strains of senescence-accelerated mice (SAM) with age-related deficits in learning and memory. Exp Gerontol, 1997, 32: 161-170.
  • 3Yagi H, Katoh S, Akiguchi I, et al. Age-related deterio- ration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Brain Res, 1988, 474: 86-93.
  • 4Koji Tomobe, Yasuyuki Nomura. Neurochemistry, Neu- ropathology, and Heredity in SAMP8: A Mouse Model of Senescence. Neurochem Res, 2009, 34: 660-669.
  • 5Canudas AM, Gutie,Tez-Cuesta J, Rodrfguez MI, at al. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM) . Mech Ag- ing Dev, 2005, 126: 1300-1304.
  • 6Del Valle J, Duran-Vilaregut J, Manich G, et al. Earlyamyloid accumulation in the hippocampus of SAMP8 mice. J Alzheimers Dis, 2010, 19: 1303-1315.
  • 7Morley JE, Farr SA, Kumar VB, et al. The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer disease. Curr Pharm Des, 2012, 18: 1123- 1130.
  • 8Casadestis G, Gutierrez-Cuesta J, Lee HG, et al. Neuro- nal cell cycle re-entT markers are altered in the senes- cence accelerated mouse P8 (SAMP8) . J Alzheimers Dis. 2012 30 (3): 573-583.
  • 9孙异临,盛树力,曲宝清,邹春林.实验性脑老化动物模型海马区的超微结构研究[J].中国医学影像学杂志,2001,9(2):122-125. 被引量:11

共引文献8

同被引文献17

  • 1杨志勇,汪华侨,张革,林贤,谢瑶,袁群芳,姚志彬.国人外周血抗β-淀粉样蛋白抗体水平的依龄性变化[J].中山大学学报(医学科学版),2005,26(2):125-128. 被引量:8
  • 2李少兵,汪华侨,林贤,徐杰,姚志彬.接种Aβ_(42)全肽疫苗恒河猴的特异性体液免疫应答[J].细胞与分子免疫学杂志,2005,21(2):202-204. 被引量:6
  • 3Gilda Shayan,Basia Adamiak,Leila H. Choe,Norman Relkin,Kelvin H. Lee.Longitudinal effects of intravenous immunoglobulin on A lzheimer’s cerebrospinal fluid proteome[J]. ELECTROPHORESIS . 2014 (12-13)
  • 4Dennis J. Selkoe.Clearing the Brain’s Amyloid Cobwebs[J]. Neuron . 2001 (2)
  • 5Monica Di Luca,Francesca Colciaghi,Lucia Pastorino,Barbara Borroni,Alessandro Padovani,Flaminio Cattabeni.Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein[J]. European Journal of Pharmacology . 2000 (1)
  • 6Shihua Xu,Felicia Gaskin.Increased incidence of anti- β -amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer’s disease[J]. Mechanisms of Ageing and Development . 1997 (1)
  • 7K. Trieb,G. Ransmayr,R. Sgonc,H. Lassmann,B. Grubeck-Loebenstein.APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer’s Disease[J]. Neurobiology of Aging . 1996 (4)
  • 8Monsonego A,Maron R,Zota V,Selkoe D J,Weiner H L.Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America . 2001
  • 9McLaurin J,Cecal R,Kierstead M E,Tian X,Phinney A L,Manea M,French J E,Lambermon M H L,Darabie A A,Brown M E,Janus C,Chishti M A,Horne P,Westaway D,Fraser P E,Mount H T J,Przybylski M,St George-Hyslop P.Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nature Medicine . 2002
  • 10Morgan D,Diamond D M,Gottschall P E,Ugen K E,Dickey C,Hardy J,Duff K,Jantzen P,DiCarlo G,Wilcock D,Connor K,Hatcher J,Hope C,Gordon M,Arendash G W.A beta peptide vaccination prevents memory loss in an animal model of Alzheimer’s disease. Nature . 2001

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部